CD36 and breast carcinoma: In addition, neutralizing antibodies against the fatty acid receptor CD36 almost completely prevent metastatic initiation, and significantly induce metastatic regression to different organs including lymph-nodes, lungs, liver, and bones, in models of melanoma, and oral and breast carcinomas 13.